-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Evoke Pharma Inc quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Evoke Pharma Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.22M, a 31.4% increase year-over-year.
- Evoke Pharma Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$6.22M, a 17.8% increase year-over-year.
- Evoke Pharma Inc annual Operating Income (Loss) for 2023 was -$7.43M, a 4.56% increase from 2022.
- Evoke Pharma Inc annual Operating Income (Loss) for 2022 was -$7.79M, a 4.48% increase from 2021.
- Evoke Pharma Inc annual Operating Income (Loss) for 2021 was -$8.15M, a 37.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)